FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-6283com.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-6283comv1
21/1/188    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H.-R.
Right arrow Articles by Reed, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H.-R.
Right arrow Articles by Reed, J. C.
(The FASEB Journal. 2007;21:188-196.)
© 2007 FASEB

Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis

Hyung-Ryong Kim1,2, Han-Jung Chae1,3, Michael Thomas, Tadaaki Miyazaki4, Anna Monosov, Edward Monosov, Maryla Krajewska, Stan Krajewski and John C. Reed5

Burnham Institute for Medical Research, La Jolla, California, USA

5Correspondence: Burnham Institute for Medical Research, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. E-mail: reedoffice{at}burnham.org


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Death-associated protein-3 (DAP3) is a GTP binding protein previously implicated in both intramitochondrial protein synthesis and apoptosis. To explore the in vivo roles of DAP3, we generated and characterized DAP3-deficient mice. Homozygous dap3/ embryos died at ~ day 9.5 in utero. The dap3/ embryos and placentas were markedly shrunken. Embryos had arrested development, displaying severe growth restriction and lack of axial turning. Transmission electron microscopy analysis revealed abnormal, shrunken mitochondria with swollen crystae in dap3/ embryos. Levels of cytochrome c oxidase-I, a protein encoded in the mitochondrial genome, were reduced in dap3/ embryos, consistent with a role for DAP3 in intramitochondrial protein synthesis. A requirement for DAP3 in mitochondrial respiration was also revealed by oxygen consumption measurements using cultured cells treated with DAP3-specific small interfering RNA (siRNA). Studies of cultured cells from dap3/ embryos confirmed a role in apoptosis induced by stimuli that trigger the extrinsic (TNF{alpha}, TRAIL, anti-Fas antibody) but not intrinsic (mitochondrial) cell death pathway. Thus, DAP3 joins a growing list of bifunctional proteins that play roles in normal mitochondrial physiology and in apoptosis.—Kim, H-R, Chae, H-J., Thomas, M., Miyazaki, T., Monosov, A., Monosov, E., Krajewska, M., Krajewski, S., Reed, J. C. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis.


Key Words: mitochondrial respiration • DAP3 protein • genotypic analysis • ß-actin • GTP binding protein


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
DEATH-ASSOCIATED PROTEIN-3 (DAP3) is an evolutionarily conserved GTP binding protein of uncertain function. Recent studies suggest that DAP3 localizes predominantly to mitochondria in most cells and may be a component of the mitochondrial ribosome (1) . The DAP3 protein of mammals is predicted to have an N-terminal leader peptide typical of nuclear genome-encoded proteins that are imported into mitochondria; fusion with this N-terminal leader peptide directs heterologous proteins into mitochondria (2) . Mutagenesis experiments also suggest that deleting this domain results in failed mitochondrial import of DAP3 in mammalian cells. Mass spectrometry analysis of isolated mitochondrial ribosomes from yeast identified the apparent yeast ortholog of DAP3 (YGL129C) (yDAP3) among the 15 proteins associated with this macromolecular assembly (3) . Investigation of yDAP3-deficient yeast (YGL129C) (yDAP3) revealed a requirement for mitochondrial DNA synthesis and mitochondrial respiration, with yDAP3-deficient yeast cells significantly defective in maintenance of the mitochondrial genome. Furthermore, the tendency to lose mitochondrial DNA in yDAP3 null mutants was significantly mitigated upon expression of the mouse DAP3 ortholog, thus demonstrating evolutionarily conserved function of DAP3 homologues among eukaryotes (4) . In addition to mitochondrial ribosome function, a role has been proposed for mammalian DAP3 in mitochondrial fission (5) . DAP3 protein stability appears to depend on preservation of the mitochondrial genome, as shown by experiments with rho-zero cells (6) .

Although a role for DAP3 in mitochondrial physiology has begun to emerge, the gene encoding this protein was first recognized for its role in apoptosis regulation, where antisense-mediated reductions in its expression in human tumor cell lines were associated with resistance to apoptosis induced by certain cytokines (7) . In addition, expression of mutants of DAP3 protein can also have an apparent dominant-negative effect, suppressing apoptosis induced via tumor necrosis factor (TNF) family death receptors. Mitochondria are recognized for their important role in apoptosis, and ample precedence exists for mitochondrial proteins participating in cell death regulation (8 , 9) . However, previous attempts to explore the role of DAP3 in apoptosis regulation in human tumor cell lines by use of antisense and dominant-negative experiments have generally failed to demonstrate a requirement for DAP3 in cell death pathways where mitochondria participate, showing instead a role for this protein in a mitochondria-independent pathway for apoptosis induced by TNF family members (10 , 11) . Moreover, it has been shown that some portion of the DAP3 protein in cells can be found in the cytosol associating with components of TNF family death receptor complexes, particularly the adapter protein FADD (11 , 12) . While evidence of a pool of cytosolic DAP3 in some types of intact cells has been obtained by immunofluorescence and subcellular fractionation (12) , some experiments have suggested that DAP3 only associates with FADD after experimental lysis of cells, causing release of DAP3 from mitochondria (13) . Nevertheless, DAP3 is reportedly phosphorylated in an Akt-dependent manner, correlating with suppression of DAP3-facilitated apoptosis (14) , thus suggesting a cytosolic role for this interesting GTP binding protein.

To explore the role of the DAP3 protein in vivo, we generated mice with homozygous disruption of the dap3 gene. Our findings reveal that dap3 gene ablation results in an embryonic lethal phenotype, associated with aberrant mitochondria morphology and reduced production of proteins encoded by the mitochondrial genome. We also show that cultured cells in which DAP3 protein expression has been ablated have defective respiration. However, cells cultured from dap3/ embryos also display a reduction in sensitivity to apoptosis induced via TNF family death receptors. Thus, we hypothesize that the predominant role for the DAP3 protein in vivo concerns maintenance of mitochondrial function, but that an additional role for DAP3 as a facilitator of certain apoptosis pathways also exists. As such, DAP3 joins a growing list of mitochondrial proteins (e.g., cytochrome c, AIF, endonuclease G, Bit) that have dual functions in both mitochondrial physiology and cell death regulation.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Generation and genotyping of dap3–/– mouse embryos
The dap3/ mice were generated by Lexicon Genetics, Inc. (Woodland, TX, USA). Briefly, mouse lines were generated by microinjection of OmniBank ES cell clone OST147863 into host blastocysts (www.lexgen.com). Gene trap mutations were generated in ES cells derived from the 129/SvEvBrd strain. ES cell clones were chosen for microinjection based on confirmation of exonic or intronic insertion by the cloning of genomic insertion sites using inverse polymerase chain reaction (PCR) (15) . The chimeric mice were bred to C57BL/6J mice for several (>10) generations. All mice analyzed were of mixed genetic background (129/SvEvBrd and C57BL/6J).

PCR genotyping and Southern blot
Mouse tail genomic DNA was isolated by phenol-chloroform extraction after cell lysis with Triton X-100 and digestion with proteinase K. For some experiments, DNA was isolated from muscle tissue using QIAamp tissue kits (Qiagen, Chatsworth, CA, USA). Exons 1 and 2 of DAP3 were amplified from genomic DNA. The forward primer used for exon 1 was 5'-ATGAGATGCTGGTAGTAAAAATTAGCTAACC-3'; the reverse primer for intron 2 was 5'-GTTCTGGAGATGAATGGAACGC-3'. The reverse primer used for the retroviral targeting vector was 5'-AAATGGCGTTACTTAAGCTAGCTTGC-3'. The PCR reaction cycle for both sets of primers was 94°C for 5 min, 94°C for 30 s, and 60°C for 60 s, for 35 cycles, with a final extension at 72°C for 10 min. The PCR product of DAP3 wild-type (WT) gene is ~350 bp in length; that of heterozygote is ~350 and ~200 bp and that of knockout cells is ~200 bp.

For Southern blot, mouse embryo genomic DNA was isolated by digesting cells in lysis buffer (100 mM Tris-Cl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 100 µg/ml proteinase K) for 5 h at 37°C and spooling genomic DNA after adding an equal volume of isopropyl alcohol. The DNA was digested overnight with Bgl-I and HindIII endonucleases and size-fractionated by agarous gel electrophoresis (0.8%). Before transfer, gels were soaked in denaturing solution (1.5 M NaCl, 0.5 M NaOH) for 1 h, followed by a 1 h wash in pH neutralization solution (1.5 M NaCl, 1 M Tris-HCl at pH 7.4). The gels were then rinsed with 20x saline sodium citrate (SSC) (3 M NaCl, 300 mM trisodium citrate at pH 7.0) for 10–15 min and transferred to Hybond N membranes overnight using the Turboblotter system (Scleicher and Schuell, Keene, NH, USA) according to the manufacturer’s protocol. After rinsing with 6x SSC, the membranes were UV cross-linked (Stratalinker ®; Stratagene, San Diego, CA, USA). A probe covering the first intron of DAP3 (~200 bp) was random primed or nick translated in the presence of 32P-{alpha}-cytidine triphosphate, and unincorporated nucleotides were removed by gel filtration (Biospin P30; Bio-Rad, Hercules, CA, USA). The probe was phenol-chloroform-extracted and boiled before addition to the hybridization solution. After 12 h of hybridization, the membranes were washed twice with 2x SSC, 0.1% SDS at 42°C and 30°C, respectively, and once with 0.2x SSC, 1% SDS at 27°C. The Hybond membranes were exposed to X-ray film with intensifying screens for 2–5 days.

For Southern blot analysis of the mitochondrial genome, total (low and high molecular weight) DNA was isolated and digested with SacII endonuclease. After gel electrophoresis and blotting as described above, the resulting blots were hybridized with a 32P-labeled, nick-translated rat 12s mitochondrial ribosome gene (gift from J. M. Cuezva).

Tissue isolation and processing
Embryos were dissected from deciduas using a surgical microscope. Whole embryos were photographed using either a phase-contrast microscope (Nikon Optiphot 66 with bright-field) or a stereomicroscope (wild M38 with MI-150 high-intensity illuminators; Dolan-Jenner Industries, Boxborough, MA, USA), both equipped with SPOT 3.1 digital cameras (Diagnostics Instruments, Inc., Sterling Heights, MI, USA). Embryonic stage was estimated by timed pregnancies and somite counts. The embryos were fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E).

Embryo/tissue harvesting, isolation, and processing
Timed pregnancies of heterozygous females were scheduled for embryo harvesting at 5.5 to 14.5 days gestation. At the earliest times (E5.5–8.5), mothers were perfused with PBS/Z-Fix solution (zinc-buffered formalin; Anatech Inc., Battle Creek, MI, USA) and the entire uteri were removed, fixed, and embedded in paraffin for histological investigation. For all remaining stages, the uteri with embryos were dissected under deep anesthesia and placed in Petri dishes containing tissue culture medium (Dulbecco with 10% FBS). Further preparation included embryo removal from deciduas under a stereomicroscope. Yolk sac vascularization status was registered. Whole, isolated embryos were photographed using either a stereomicroscope or a bright-field phase-contrast microscope. Embryonic stage for timed pregnancies at 9.5–12.5 postconception was estimated by somite counts. The embryos were postfixed in Z-Fix, embedded in paraffin, sectioned, and stained with H&E or Masson’s trichrome.

Transmission electron microscopy analysis
Whole E9.5 embryos were fixed with Karnovsky standard 2% formalin and 2% glutaraldehyde in 0.1 M cacodylate buffer solution (pH 7.4) (16) at room temperature, washed, and postfixed in 1% osmium tetroxide in the same buffer. Samples were dehydrated in ethanol, then embedded in Eponate 12 epoxy resin (Ted Pella Inc., Redding, CA, USA) and sectioned on Reichert-Jung Ultracut microtome. Semithin sagittal sections of whole embryos were stained with Toluidine blue to locate and mark the heart regions. The tissue was then trimmed around areas of interest for ultrathin sectioning. The ultrathin sections were stained with uranyl acetate, followed by lead citrate, and imaged using a Hitachi H-600 electron microscope at 75 kV.

For morphometric analysis, electron microscopy (EM) micrographs of ultrathin sections were scanned at a resolution of 2000 ppi using a DuoScan T2500 (Agfa Corp., Ridgefield Park, NJ, USA). The digitized images were subjected to morphometric analysis using Image Pro Plus, v.4.5 (Media Cybernetics, Silver Spring, MD, USA). Measurements of cell areas and areas of mitochondria of WT (dap3+/+) and knockout (dap3/) cells were exported into MS Excel 2002. Statistical significance of data was determined by an unpaired t test.

Immunoblot analysis
Protein samples (50 µg) were mixed with an equal volume of 2x SDS sample buffer, boiled for 5 min, then subjected to SDS-PAGE (10 or 12.5% gels). After electrophoresis, proteins were transferred to nitrocellulose membranes by a semidry electrophoretic transfer method. The membranes were blocked in a Tris-buffered saline (TBS) containing 10 mM Tris (pH 7.4), 150 mM NaCl) 5% dry milk (1 h), then rinsed and incubated with primary antibodies 1:100 v/v, rabbit anti-DAP3 (IgG, #IMG-295, Imagenex Technology Corp., Port Coquitlam, BC, Canada) or -HSP60 (clone LK-1, IG1, #SPA-806; Stressgen Bioreagents Corp., Ann Arbor, MI, USA) in TBS (10 mM Tris [pH 7.4], 150 mM NaCl) overnight at 4°C. Membranes were washed four times in TBS, then 0.1 µg/ml peroxidase-labeled mouse or rabbit secondary antibody (Ab) was added for 1 h. After four washes in TBS, bands were visualized by enhanced chemiluminescence with exposure to X-ray film. After photography, the same blot was stripped frequently for 15 min in 0.2 M glycine, pH 2.5, preblocked, and immunolabeled with additional antibodies as above.

Mouse embryo cell cultures
Embryos from pregnant mice at day 9 postcoitus were sacrificed. Both uterine horns containing the fetuses were taken and the deciduas were separated away. Yolk sacs with amnion were collected for genotyping. Cell suspensions from whole fetuses were generated in Dulbecco’s modified Eagle medium (DMEM) -F12 medium (Life Technologies, Carlsbad, CA, USA) by mincing tissue with 30 gauge needles, followed by partial digestion in trypsin-EDTA (Life Technologies) supplemented with collagenase (Sigma, St. Louis, MO, USA; C-9891) at 0.5% w/v trypsin and 20 µg/ml collagenase final concentrations. The cell suspension was plated on fibronectin (Invitrogen, Carlsbad, CA, USA) -coated (15 µg/ml) 12-well dishes in DMEM-F12 containing 15% FBS, 2% penicillin/streptomycin, 50 µg/ml L-uridine (Sigma), 0.1 mM nonessential amino acids (Invitrogen), and 1 mM sodium pyruvate (Sigma). Cells were cultured at 37°C in 95% air/5% CO2.

HeLa cell culture and siRNA transfections
HeLa human cervical carcinoma cells were maintained in DMEM medium supplemented with 10% heat-inactivated FBS, penicillin G (100 IU/ml), streptomycin (100 µg/ml), and L-glutamate (2 mM) and cultured at 37°C in a humidified atmosphere containing 5% CO2 and 95% air. Exponentially growing HeLa cells were seeded at 106 cells per 6-well plate or at 107 cells per 10 mm dish, then cells were exposed to various agents as indicated below. Twenty-one nucleotide pair, double-stranded RNA were chemically synthesized, deprotected, and purified by Dharmacon Research Inc. (Lafayette, CO, USA). The sequence of the sense strand of the DAP3 siRNA is 5'-CCAGGTTCCAGTTGAGAGT-3'. A mutant DAP3 siRNA of sequence 5'-CCGAGTTCCAGTTGAGAGT-3' was used as a negative control. Transfection of siRNA duplexes was performed using oligofectamine (Invitrogen). HeLa cells in 0.2 µl medium in 24-well plates at 30–50% confluence were transfected with 2 µl oligofectamine and 3 µl of siRNA containing 60 pmol dsRNA. Cells were incubated in DMEM without serum or antibiotics at 30°C for 5 h, then replaced with DMEM containing 10% FBS and antibiotics. At 2 days post-transfection, cells were lysed and immunoblotted with DAP3 Ab.

Oxygen consumption measurements
Cellular oxygen consumption rates were measured as described previously (17) . Aliquots of cells were placed into a respirometer fitted with a polarographic oxygen electrode. The electrode was calibrated with a humidified gas mixture containing various oxygen levels. Carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP) (Sigma) (5 µM) or Gramicidin D (Sigma) (1 µg/ml) was added directly to the cell suspensions in the respirometer and the resultant rate of oxygen consumption was measured.

Viability assays
Mouse embryonic cells were seeded at 20,000 cells per well in 96-well dishes and allowed to attach overnight. Cells were then treated with cycloheximide (Sigma) at 10 µg/ml and agonistic Fas Ab (clone Jo2, BD PharMingen, San Diego, CA, USA), mouse recombinant TNF{alpha} (R&D Systems, Minneapolis, MN, USA), or human TRAIL (BIOMOL) at various concentrations. Alternatively, cells were treated with staurosporine or etoposide (both from Sigma) at increasing concentrations without cycloheximide. Cells were treated overnight, then assayed by MTS (Promega, Madison, WI, USA). Percentage viability was calculated from optical density at 490 nm readings taken with a Powerwave x340 ELISA plate reader (Bio-Tek Instruments, Inc., Winooski, VT, USA) by normalizing readings to control values from untreated cells.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Targeted ablation of the dap3 gene in mice
We searched the Lexicon Genetics database of ES cell clones containing random retroviral insertions, identifying four clones with insertions within the dap3 gene. Inspection of the exon-intron organization of the dap3 gene, in combination with the sequence data available at www.lexgen.com, suggested sites of integration within exons 1 and 2. Using the ES clone in which the retroviral insertion was deduced to have occurred in intron 1 (Fig. 1 A), a line of heterozygous mice was produced that contained one targeted and one normal dap3 allele. A PCR was designed using amplification primers flanking the insertion site in dap3 and used for genotyping mice and embryos (Fig. 1B ). Southern blot analysis also confirmed the presence of the proviral insertion in intron 1 (Fig. 1B ).


Figure 1
View larger version (22K):
[in this window]
[in a new window]

 
Figure 1. Genotypic analysis of dap3–/– embryos. A) A schematic of the retrovirus-targeted mouse dap3 gene is presented based on DNA sequence data for the DAP311 Omnibank mouse line in conjunction with mouse genomic sequence from contig 92070 (GenBank). The location of the retroviral insert in intron I is shown, as well as the primers used to create PCR-based assays. The approximate location of BglI and HindIII restriction endonuclease sites used for Southern blot analysis are also shown. B) left: PCR-based analysis of genomic DNA from dap3+/+, dap3±, and dap3/ embryos was performed using primers A and B flanking the retroviral insertion site in intron I. Molecular weight markers (M) are indicated in base pairs. Data are representative of at least 30 mice analyzed for each genotype. C) right: Southern blot analysis was performed using BglI and HindIII-digested genomic DNA from embryos, employing a 32P-labeled DAP3 probe ({approx}700 bp containing 1st exon and the 1st intron proximal to the insertion site of the retroviral vector). Molecular weight markers are indicated in kilobase pairs. Data are representative of at least 3 mice analyzed for each phenotype.

Homozygous targeting of dap3 is embryonic lethal
Attempts to breed dap3± mice to homozygosity never resulted in live offspring among >50 successful dap3± matings, suggesting that homozygous dap3 gene ablation is embryonic lethal. Inspection of embryos from timed pregnancies, in combination with PCR-based genotyping, indicated that dap3/ embryos fail to progress beyond E9.5. A comparison of E9.5 embryos of dap3+/+ and dap3/ embryos revealed that the dap3/ embryos were markedly shrunken and poorly developed (Fig. 2 A, B). Though rostral-caudal relations were preserved, these embryos lacked axial turning and appeared to be highly anemic. Histological examination showed that although the placenta of dap3/ embryos was smaller, it nevertheless appeared to be properly formed initially, but deteriorated later in some embryos (Fig. 2C ). In contrast, heterozygous dap3± embryos developed normally (not shown).


Figure 2
View larger version (52K):
[in this window]
[in a new window]

 
Figure 2. Morphology of dap3–/– embryos. Whole mounts of E9.5 dap3/ embryos are compared with dap3+/+ littermates. A) Dark-field analysis of embryos is shown at 40x original magnification. B) A comparison of E9.5 intact embryos is shown to illustrate the difference in size. C) Histological analysis of dap3/ embryos. E9.5 embryos were fixed, embedded in paraffin, and sectioned. Photomicrographs represent H&E staining data (x40). The left and middle panels show sections of dap3+/+ and dap3/ embryos, respectively, after extraction from yolk sac and placental tissues. The right figure shows a section of a dap3–/– embryo in utero. Data are representative of at least 10 mice of each genotype.

Defective mitochondria in dap3–/– embryos
To further evaluate the defects in dap3/ embryos, we performed transmission electron microscopy (TEM) analysis. Unlike dap3+/+ and dap3± embryos, cells within dap3/ embryos contained mitochondria with abnormal morphology in all tissues examined. Two types of abnormal mitochondria were observed, including mitochondria with overall normal size and shape, but with swollen cristae and mitochondria that were shrunken with increased electron density (Fig. 3 ). In contrast, no abnormalities were noted in other organelles (Golgi, ER, nuclear envelope, lysosomes) of dap3/ embryos by EM analysis (Fig. 3 and data not shown).


Figure 3
View larger version (200K):
[in this window]
[in a new window]

 
Figure 3. EM analysis of dap3–/– embryos reveals abnormal mitochondria. EM analysis was performed for dap3+/+ (A, B) and dap3/ (C, D) embryos, using tissue from the heart region to ensure uniformity of tissue sampling. Data are presented at two magnifications: low (A, C) and high (B, D). Mitochondria have normal morphology in dap3+/+ embryos. In dap3/ embryos, many mitochondria have aberrant morphologies characterized by partially ruptured inner and outer membranes, swollen intracristal spaces (single-headed arrows). Some mitochondria appear to have collapsed into electron dense, shrunken remnants (double-headed arrow). Note that ER and other organelles appear normal in both dap3+/+ and dap3/ embryos. Data are representative of at least 3 embryos analyzed for each genotype.

Morphometric analysis of mitochondria of dap3+/+ and dap3/ embryos revealed that the average size of mitochondria was ~2.0-fold smaller (P=0.0002) in dap3/ embryos at E9.5 than dap3+/+ embryos (Fig. 4 ). In contrast, no statistically significant difference was detected in the average number of mitochondria per cell (Fig. 4) or overall size of cells of dap3/ embryos as judged from surface area measurements using the same TEM data (not shown). The dap3+/+ and dap3± embryos were indistinguishable (not shown).


Figure 4
View larger version (13K):
[in this window]
[in a new window]

 
Figure 4. Morphometric analysis of mitochondria in dap3–/– embryos. Morphometric analysis of cells and mitochondria in the developing hearts of dap3+/+ and dap3/ embryos was performed at E9.5. Data represent mean ± SD (n>34), measuring A) number of mitochondria per cell unit/area; B) percentage of mitochondria with normal morphology per cell unit/area; and C) area of mitochondria per cell unit/area. Data for dap3+/+ and dap3–/– embryos in panels B, C are statistically different (P<0.05 by an unpaired t test), and were derived from analysis of at least 3 embryos of each genotype. "n" refers to the number of cells analyzed.

Characterization of mitochondria in DAP3-deficient cells
The altered size and density of dap3–/– mitochondria made it difficult to obtain high-quality isolation of these organelles. We therefore sought alternative ways of characterizing some of the properties of mitochondria in dap3/ embryos. Immunoblot analysis confirmed that dap3/ embryos fail to produce the DAP3 protein (Fig. 5 A). The absence of DAP3 protein was also confirmed by immunohistochemical analysis of dap3/ embryos (not shown). Equal loading of protein samples was confirmed by probing the same blots with antibodies recognizing cytosolic ß-actin and mitochondrial Hsp60, a resident mitochondrial protein encoded in the nuclear genome. Note that all of the detectable Hsp60 migrated as the mature form of the protein, indicative of removal of the N-terminal leader peptide during import into mitochondria. Moreover, immunostaining of dap3–/– embryos revealed punctuate localization of Hsp60 protein in cytosol of cells, typical of mitochondria-targeted proteins (not shown). However, in dap3/ embryos we observed reduced levels of cytochrome c oxidase-I (COI), a protein encoded in the mitochondrial genome that is produced within these organelles by transcription and translation from the mitochondrial gene expression machinery (Fig. 5A ). Scanning densitometry analysis of blots suggested a decrease in COI protein levels of approximately half compared with dap3+/+ embryos after normalization for Hsp60 or ß-actin. The defect in COI expression was not secondary to fewer mitochondria genomes on average, as determined by quantitative Southern blot analysis of low molecular weight DNA (Fig. 5B ).


Figure 5
View larger version (18K):
[in this window]
[in a new window]

 
Figure 5. Molecular analysis of mitochondria in dap3–/– embryos. A) Detergent lysates were prepared from E9.5 embryos, normalized for total protein content, and analyzed by SDS-PAGE/immunoblotting using antibodies recognizing (from top to bottom): DAP3; COI; Hsp60, and ß-actin. Proteins shown migrated according to their predicted molecular masses, based on comparisons to protein molecular weight standards (not shown) for 46 kDa DAP3, 57 kDa COI, 60 kDa Hsp60, and 42 kDa actin. B) Total DNA was isolated from E9.5 embryos, digested with SacII, then 10 µg was analyzed by Southern blot using a 32P-labeled probe corresponding to the rat 12s mitochondrial ribosomal gene. Data in panels A, B are representative of at least two independent experiments.

Mammalian DAP3 is required for oxidative respiration
To ascertain the respiratory competency of DAP3-deficient cells, we used an oxygen electrode to measure oxygen consumption in intact cells. Because we were unable to grow sufficient numbers of dap3/ cells from embryos to accomplish these O2 consumption measurements, we resorted to use of established cell lines in which DAP3 expression was ablated by transfection of small interfering RNA (siRNA). As shown in Fig. 6 A, transfection of DAP3 siRNA oligonucleotides into HeLa cells resulted in essentially complete loss of DAP3 protein production, while a mismatched control RNA duplex did not. Oxygen consumption by DAP3-deficient HeLa cells was reduced ~5-fold compared with control cells (Fig. 6B ), indicating that DAP3 protein is required for mitochondrial respiration.


Figure 6
View larger version (14K):
[in this window]
[in a new window]

 
Figure 6. Defective respiration in DAP3-deficient cells. HeLa cells were cultured without treatment (CNTL) or transfected with DAP3-specific siRNA vs. control (mutant) siRNA by lipofection, then analyzed 1 day later. A) Immunoblot analysis was performed using detergent lysates normalized for total protein content. Blots were incubated with antibodies recognizing DAP3 (top) or ß-actin (bottom). B) Oxygen consumption was measured using a pO2 electrode, expressing data as a percentage relative to maximal O2 consumption achieved by culturing cells with protonophore FCCP (mean±SD; n=3). Data are representative of at least 3 independent experiments.

Defective apoptosis in DAP3-deficient cells
It has been reported that antisense-mediated reductions in DAP3 reduce the sensitivity of tumor cell lines to apoptosis induction by TNF family death receptors and ligands, including Fas and TNF. We therefore, examined the sensitivity of mouse embryonic cells derived from dap3+/+ vs. dap3/ embryos to apoptosis-inducing agents. Cells cultured from dap3/ embryos grew very little in culture. Despite the use of media adapted for culturing rho-zero cells with mitochondrial defects, dap3/ cells from E9.5 embryos were capable of surviving but did not propagate significantly in culture. Attempts to immortalize dap3/ cells by infection with recombinant retroviruses encoding SV40 large T antigen were also unsuccessful.

We therefore explanted embryonic dap3/, dap3±, and dap3+/+ cells into culture on 24-well plates and used them within 24 h for cell death assays. When challenged with staurosporine (STS), a broad-spectrum kinase inhibitor that induces apoptosis via the intrinsic pathway, little difference in apoptosis sensitivity was noted in comparisons of dap3/ and dap3+/+ MEFs (Fig. 7 ). Similarly, a challenge with VP16, a DNA-damaging agent, revealed no significant difference in cell death induced in cultures of dap3+/+, dap3±, or dap3/ cells (not shown). In contrast, dap3/ cells demonstrated reduced sensitivity to cell death induced by stimulation of TNF family death receptors using TNF, TRAIL, or anti-Fas Ab in combination with cycloheximide. Cells from dap3± heterozygous embryos exhibited intermediate sensitivity (Fig. 7) . Similar results were obtained in experiments where the percentages of apoptotic cells were evaluated by staining with FITC-annexin V and propidium iodide (not shown). We conclude therefore that loss of dap3 expression is associated with reduced sensitivity of mouse embryonic cells to apoptosis induced via TNF family death receptors, consistent with prior results obtained by use of antisense methods.


Figure 7
View larger version (23K):
[in this window]
[in a new window]

 
Figure 7. DAP3-deficient cells display reduced sensitivity to apoptosis induced by extrinsic pathway stimuli. Mouse embryonic cells from dap3+/+, dap3±, and dap3/ embryos were cultured with 10 µg/ml cycloheximide (CHX) alone or in combination with 0.05 µg/ml TNF (upper left), 200 ng/ml Jo2 anti-Fas Ab (upper right), or 0.1 µg/ml TRAIL (lower left). Alternatively, cells were cultured with STS (lower right). After 2 days the percentage of viable cells was determined by MTS assay (mean±SD; n=3), expressing data as a % of cultures treated with cycloheximide alone (for TNF, Fas, and TRAIL) or as a % of control untreated cultures (for STS).


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
In this report, we demonstrate that dap3 is an essential mammalian gene. Embryos lacking dap3 are shrunken and have massively arrested development, dying at ~ E9.5. Mitochondria in these developing embryos show morphological defects, including reduced size and swollen crystae, whereas other organelles appear to be intact. These observations are consistent with prior data indicating that DAP3 is imported into mitochondria, where it associates with mitochondrial ribosomes. It has been speculated that DAP3 functions akin to other GTP binding proteins involved in ribosome-mediated translation of mRNAs, including Ski7p of Saccharomyces cereviasiae and EF-Tu of Homo sapiens (18 , 19) . One of the GTP binding proteins, EF-Tu (elongation factor Tu) in the GTP-bound conformation forms a high-affinity complex with aminoacyl-tRNA that binds to the ribosomal A site. In addition, the Ski7p’s C-terminal region, which has homology to the GTPase domains of EF1A (the translation elongation factor), can bind the empty A site on the ribosome stalled at the 3' end of RNAs. As a result of GTP hydrolysis, EF-Tu changes conformation from the GTP to the GDP form, where it loses the affinity for aa-tRNA. Consistent with a potential role for DAP3 in mitochondrial protein synthesis, we observed that levels of a protein encoded in the mitochondrial genome (COI) are reduced in DAP3-deficient tissues.

Several proteins encoded in the mitochondrial genome are required for respiration, and thus we predicted that DAP3-deficient tissues would show defects in oxygen consumption. Due to the inability to obtain sufficient numbers of intact mitochondria from dap3/ embryos, we addressed this question by using siRNA to reduce DAP3 protein production in cultured intact cells. Indeed, the loss of DAP3 expression resulted in significant impairment of respiration, consistent with previous data from yeast where disruption of yDAP3 (YGL129c) renders cells unable to grow on substrates that require aerobic metabolism (20) .

A curious property of DAP3 is that it not only plays important roles in mitochondrial physiology, but also participates in apoptosis. DAP3 was first identified in an antisense screen for genes required for cytokine-induced apoptosis (7) and was shown to be involved in cell death pathways activated by TNF family cytokine receptors (e.g., Fas; TRAIL-Rs; TNFR1) but not pathways induced by DNA-damaging agents or the broad-spectrum kinase inhibitor STS (10) . DNA-damaging agents and STS are known to induce cell death through a mitochondria-dependent pathway involving release of cytochrome c from these organelles (21 , 22) , whereas TNF family death receptors can induce apoptosis through either mitochondria-independent or -dependent mechanisms, depending on the type of cell examined (23 , 24) . Previously, we showed that a cytosolic pool of DAP3 exists in many cell lines, in addition to the mitochondrial pool of DAP3 (12) , and demonstrated that DAP3 protein associates with TNF family death receptor complexes, where we speculate that it operates as a chaperone to facilitate assembly of the caspase-activating complex known as the "death-inducing signaling complex" (11) . Here we extended these studies showing that cells from dap3/ embryos undergo significantly less apoptosis when stimulated with agonists of TNF family death receptors compared with dap3+/+ cells. Heterozygous dap3± cells showed an intermediate reduction in sensitivity to cell death induction by TNF family death receptors.

It has been suggested that DAP3 regulates mitochondrial fission (5) . A role for mitochondrial fission in cell death has emerged recently, with many apoptosis-inducing agents triggering this phenomenon and several proteins implicated in mitochondria fusion/fission showing an ability to modify the kinetics of cell death in vitro (reviewed in ref. 25 ). At present, it is unclear whether the effects of DAP3 on mitochondrial fission represent a direct (proximal) effect of this GTP binding protein on some aspect of the fission mechanism vs. an indirect (distal) reflection of its role in regulating apoptosis.

Though many questions remain to be resolved about the roles of DAP3 in both mitochondrial physiology and apoptosis, the findings reported here provide further evidence that DAP3 is a bifunctional protein and, as such, is similar to several other mitochondrial proteins that have been reported to have dual functions in both mitochondrial biology and cell death regulation. For example, cytochrome c is required for electron transfer from complex III to IV in mitochondria, but also is an essential activator of Apaf1, a caspase-activating protein (26 , 27) . HtrA2 is a mitochondrial serine protease homologous to the bacterial DegP/Omi protein (28) , which also binds antiapoptotic IAP family proteins when released into the cytosol, freeing caspases to induce apoptosis (29 , 30) . Bit (brain immunoglobulin-like molecule with tyrosine-based activation motifs) is a mitochondrial peptidyl-tRNA hydrolase that also modulates the activity of transcription factors controlling expression of antiapoptotic gene bcl-2 when released into the cytosol (31) . AIF is a mitochondrial flavoprotein of unknown function that is released into cytosol and enters the nucleus to promote genome digestion during apoptosis (32) . Endonuclease G is a mitochondrial protein involved in mitochondrial DNA replication that is released into the cytosol during apoptosis and induces nuclear DNA fragmentation (33) . These mitochondrial proteins are all encoded in the nuclear genome, undergo import into mitochondria, and sort to the intermembrane space between the inner and outer membranes of these organelles, becoming released into the cytosol during apoptosis. In contrast, DAP3 is sorted to the matrix of mitochondria and does not appear to be released into cytosol during apoptosis (5 , 13) . Under normal conditions, however, a pool of nonmitochondrial DAP3 appears to be resident in cells, the amount varying among cell lines examined (12) . The cytosolic activity of DAP3 is known to be regulated by phosphorylation, where Akt (PKB) -mediated phosphorylation of DAP3 inhibits its proapoptotic role in the context of signaling by TNF family death receptors (14) . Thus, the participation of DAP3 in apoptosis may be regulated at several levels, including 1) gene expression; 2) protein localization (sequestration in mitochondria); and 3) phosphorylation. Additional studies of this interesting GTP binding protein may help provide further insight into its biochemical mechanisms and DAP’s dual functions in mitochondrial physiology and cell death regulation.


   ACKNOWLEDGMENTS
 
We thank C. L. Kress for animal husbandry, X. Huang and W-S. Kwon for histology, C. Duester and M. Mercola for analysis of embryos, M. Hanaii and J. Valois for manuscript preparation, A. Kimchi for dap3 cDNA, and the National Institutes of Health (GM-61694 and GM 60554 to J.C.R. and NS036821 to S.K.) for generous support.


   FOOTNOTES
 
1 These authors contributed equally to this work.

2 Present address: Department of Dental Pharmacology, School of Dentistry, Wonkwang University, Iksan, Chonbuk, South Korea.

3 Present address: Department of Pharmacology, School of Medicine, Chonbuk National University, Jeonju, Chonbuk, South Korea.

4 Present address: Department of Bioresources, Hokkaido University, Research Center for Zoonoisis Control, North-21, West-11, Kita-ku, Sapporo 001-0021, Japan.

Received for publication April 19, 2006. Accepted for publication August 7, 2006.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Saveanu, C., Fromont-Racine, M., Harington, A., Ricard, F., Namane, A., Jacquier, A. (2001) Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues. J. Biol. Chem. 276,15861-15867[Abstract/Free Full Text]
  2. Morgan, C. J., Jacques, C., Savagner, F., Tourmen, Y., Mirebeau, D. P., Malthiery, Y., Reynier, P. (2001) A conserved N-terminal sequence targets human DAP3 to mitochondria. Biochem. Biophys. Res. Commun. 280,177-181[CrossRef][Medline]
  3. Gan, X., Kitakawa, M., Yoshino, K., Oshiro, N., Yonezawa, K., Isono, K. (2002) Tag-mediated isolation of yeast mitochondrial ribosome and mass spectrometric identification of its new components. Eur. J. Biochem. 269,5203-5214[Medline]
  4. Berger, T., Brigl, M., Herrmann, J. M., Vielhauer, V., Luckow, B., Schlöndorff, D., Kretzler, M. (2000) The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins. J. Cell Sci. 113,3603-3612[Abstract]
  5. Mukamel, Z., Kimchi, A. (2004) Death-associated protein 3 localizes to the mitochondria and is involved in the process of mitochondrial fragmentation during cell death. J. Biol. Chem. 279,36732-36738[Abstract/Free Full Text]
  6. Jacques, C., Chevrollier, A., Loiseau, D., Lagoutte, L., Savagner, F., Malthiery, Y., Reynier, P. (2006) mtDNA controls expression of the death associated protein 3. Exp. Cell Res. 312,737-745[CrossRef][Medline]
  7. Kissil, J. L., Deiss, L. P., Bayewitch, M., Raveh, T., Khaspekov, G., Kimchi, A. (1995) Isolation of DAP3, a novel mediator of interferon-{gamma}-induced cell death. J. Biol. Chem. 270,27932-27936[Abstract/Free Full Text]
  8. Green, D. R., Reed, J. C. (1998) Mitochondria and apoptosis. Science 281,1309-1312[Abstract/Free Full Text]
  9. Green, D. R., Kroemer, G. (2004) The pathophysiology of mitochondrial cell death. Science 305,626-629[Abstract/Free Full Text]
  10. Kissil, J., Cohen, O., Raveh, T., Kimchi, A. (1999) Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-{alpha} and Fas-induced cell death. EMBO J. 18,353-362[CrossRef][Medline]
  11. Miyazaki, T., Reed, J. C. (2001) A GTP binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins. Nature Immunol. 2,493-500[CrossRef][Medline]
  12. Miyazaki, T., Kim, H. R., Godzik, A., Krajewski, S., Reed, J. C. (2002) Response-interaction of DAP3 and FADD only after cellular disruption. Nature Immunol. 3,4-5[CrossRef]
  13. Berger, T., Kretzler, M. (2002) TRAIL-induced apoptosis is independent of the mitochondrial apoptosis mediator DAP3. Biochem. Biophys. Res. Commun. 297,880-884[CrossRef][Medline]
  14. Miyazaki, T., Shen, M., Fujikura, D., Tosa, N., Kim, H. R., Kon, S., Uede, T., Reed, J. C. (2004) Functional role of death-associated protein 3 (DAP3) in anoikis. J. Biol. Chem. 279,44667-44672[Abstract/Free Full Text]
  15. Silver, J., Keerikatte, V. (1989) Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J. Virol. 63,1924-1928[Abstract/Free Full Text]
  16. Graham, R. C., Jr, Karnovsky, M. J. (1965) The histochemical demonstration of monoamine oxidase activity by coupled peroxidatic oxidation. J. Histochem. Cytochem. 13,604-605[Medline]
  17. Schumacker, P. T., Chandel, N., Agusti, A. G. (1993) Oxygen conformance of cellular respiration in hepatocytes. Am. J. Physiol. 265,L395-L402[Medline]
  18. Van Hoof, A., Frischmeyer, P. A., Dietz, H. C., Parker, R. (2002) Exosome-mediated recognition and degradation of mRNAs lacking a termination codon. Science 295,2262-2264[Abstract/Free Full Text]
  19. Vasudevan, S., Peltz, S. W., Wilusz, C. J. (2002) Non-stop decay—a new mRNA surveillance pathway. Bioessays 24,785-788[CrossRef][Medline]
  20. Tizon, B., Rodriguez-Torres, A. M., Cerdan, M. E. (1999) Disruption of six novel Saccharomyces cerevisiae genes reveals that YGL129c is necessary for growth in non-fermentable carbon sources, YGL128c for growth at low or high temperatures and YGL125w is implicated in the biosynthesis of methionine. Yeast 15,145-154[CrossRef][Medline]
  21. Zhang, X. D., Gillespie, S. K., Hersey, P. (2004) Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol. Cancer Ther. 3,187-197[Abstract/Free Full Text]
  22. Stepczynska, A., Lauber, K., Engels, I. H., Janssen, O., Kabelitz, D., Wesselborg, S., Schulze-Osthoff, K. (2001) Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 20,1193-1202[CrossRef][Medline]
  23. Maianski, N. A., Roos, D., Kuijpers, T. W. (2003) Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 101,1987-1995[Abstract/Free Full Text]
  24. Marriott, J. B., Clarke, I. A., Czajka, A., Dredge, K., Childs, K., Man, H. W., Schafer, P., Govinda, S., Muller, G. W., Stirling, D. I., Dalgleish, A. G. (2003) A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Cancer Res. 63,593-599[Abstract/Free Full Text]
  25. Bossy-Wetzel, E., Barsoum, M. J., Godzik, A., Schwarzenbacher, R., Lipton, S. A. (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr. Opin. Cell Biol. 15,706-716[CrossRef][Medline]
  26. Adachi, S., Cross, A. R., Babior, B. M., Gottlieb, R. A. (1997) Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during fas-mediated apoptosis. J. Biol. Chem. 272,21878-21882[Abstract/Free Full Text]
  27. Cain, K., Bratton, S. B., Cohen, G. M. (2002) The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie (Paris) 84,203-214
  28. Faccio, L., Fusco, C., Chen, A., Martinotti, S., Bonventre, J. V., Zervos, A. S. (2000) Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J. Biol. Chem. 275,2581-2588[Abstract/Free Full Text]
  29. Hedge, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., Alnemri, E. S. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277,432-438[Abstract/Free Full Text]
  30. Martins, L. M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N. F., Lemoine, N. R., Savopoulos, J., Gray, C. W., Creasy, C. L., Dingwall, C., Downward, J. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277,439-444[Abstract/Free Full Text]
  31. Stupack, D. G., Cheresh, D. A. (2004) A Bit-role for integrins in apoptosis. Nat. Cell Biol. 6,388-389[CrossRef][Medline]
  32. Penninger, J. M., Kroemer, G. (2003) Mitochondria, AIF and caspases–rivaling for cell death execution. Nat. Cell Biol. 5,97-99[CrossRef][Medline]
  33. Sakahira, H., Enari, M., Nagata, S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391,96-99[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Tang, B. Zheng, S.-h. Chen, A. N. Murphy, K. Kudlicka, H. Zhou, and M. G. Farquhar
hNOA1 Interacts with Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis
J. Biol. Chem., February 20, 2009; 284(8): 5414 - 5424.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-6283comv1
21/1/188    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H.-R.
Right arrow Articles by Reed, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H.-R.
Right arrow Articles by Reed, J. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS